Replies to post #2451 on Teva Pharmaceutical Industries Ltd (TEVA)

[DewDiligence]

44%(!) of TEVA’s 1Q16 profit came from a single product: Copaxone. Think about what happens to that if NVS/MNTA launch a 40mg generic in early 2017.